Consensus Statement on the Care of Heart Failure with Preserved LVEF

This document is the first to provide clinicians with guidance on caring for this population.

Sponsoring Organization: American College of Cardiology

Background and Objective

After decades of disappointing results from trials of treatments for heart failure (HF) with preserved ejection fraction (HFpEF), evidence has emerged recently to guide diagnostic testing and treatment. This consensus document provides guidance for the care of this clinically challenging population.

Key Points

The causes of dyspnea in individuals with preserved left ventricular ejection fraction (LVEF) are numerous; in addition to heart failure, noncardiac causes (e.g., lung disease) must be considered. The Universal Definition of HF requires both symptoms or signs of HF and either elevated natriuretic peptides or objective evidence of cardiogenic pulmonary or syst…

Reviewing Author

Frederick A. Masoudi, MD, MSPH, MACC, FAHA

Disclosures

Consultant/Advisory BoardBristol Myers Squibb; CPC Clinical Research

Grant/Research SupportNational Heart, Lung, and Blood Institute

Editorial BoardsUpToDate; American College of Cardiology Self-Assessment Program (SAP)

Leadership Positions in Professional SocietiesAmerican College of Cardiology (Chair, Innovations Committee)